Bionano Genomics, Inc. 0A4K.L Stock
Bionano Genomics, Inc. Price Chart
Bionano Genomics, Inc. 0A4K.L Financial and Trading Overview
Bionano Genomics, Inc. stock price | 0.99 USD |
Previous Close | 0.78 USD |
Open | 0 USD |
Bid | 0 USD x N/A |
Ask | 0 USD x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 4.34 USD |
Volume | 18.5K USD |
Avg. Volume | 27.6K USD |
Market Cap | N/A |
Beta (5Y Monthly) | 2.248013 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.328 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0A4K.L Valuation Measures
Enterprise Value | 156.46M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.99052984 |
Enterprise Value/Revenue | 5.3 |
Enterprise Value/EBITDA | -1.233 |
Trading Information
Bionano Genomics, Inc. Stock Price History
Beta (5Y Monthly) | 2.248013 |
52-Week Change | -50.28% |
S&P500 52-Week Change | 20.43% |
52 Week High | 4.34 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 0.78 USD |
200-Day Moving Average | 1.59 USD |
0A4K.L Share Statistics
Avg. Volume (3 month) | 27.6K USD |
Avg. Daily Volume (10-Days) | 20.7K USD |
Shares Outstanding | N/A |
Float | 305.06M |
Short Ratio | N/A |
% Held by Insiders | 1.82% |
% Held by Institutions | 27.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -465.70% |
Gross Margin | 24.23% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -26.83% |
Return on Equity (ttm) | -51.51% |
Income Statement
Revenue (ttm) | 29.52M USD |
Revenue Per Share (ttm) | 0.1 USD |
Quarterly Revenue Growth (yoy) | 30.19% |
Gross Profit (ttm) | 5.95M USD |
EBITDA | -126881000 USD |
Net Income Avi to Common (ttm) | -139768000 USD |
Diluted EPS (ttm) | -0.328 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 95.81M USD |
Total Cash Per Share (mrq) | 0.31 USD |
Total Debt (mrq) | 11.17M USD |
Total Debt/Equity (mrq) | 4.83 USD |
Current Ratio (mrq) | 3.738 |
Book Value Per Share (mrq) | 0.755 |
Cash Flow Statement
Operating Cash Flow (ttm) | -124735000 USD |
Levered Free Cash Flow (ttm) | -58624876 USD |
Profile of Bionano Genomics, Inc.
Country | United Kingdom |
State | CA |
City | San Diego |
Address | 9540 Towne Centre Drive |
ZIP | 92121 |
Phone | 858 888 7600 |
Website | https://bionano.com |
Industry | |
Sector(s) | |
Full Time Employees | 405 |
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
Q&A For Bionano Genomics, Inc. Stock
What is a current 0A4K.L stock price?
Bionano Genomics, Inc. 0A4K.L stock price today per share is 0.99 USD.
How to purchase Bionano Genomics, Inc. stock?
You can buy 0A4K.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bionano Genomics, Inc.?
The stock symbol or ticker of Bionano Genomics, Inc. is 0A4K.L.
How many shares does Bionano Genomics, Inc. have in circulation?
The max supply of Bionano Genomics, Inc. shares is 0.
What is Bionano Genomics, Inc. Price to Earnings Ratio (PE Ratio)?
Bionano Genomics, Inc. PE Ratio is now.
What was Bionano Genomics, Inc. earnings per share over the trailing 12 months (TTM)?
Bionano Genomics, Inc. EPS is -0.328 USD over the trailing 12 months.